Featured: Investments
Novus portfolio company TC BioPharm signs US collaboration deal.
Scottish life sciences group TC BioPharm (TCB) secures a $16 million (£12 million) strategic collaboration with US bio-tech group Bluebird to discover and develop new cancer treatments.
07/12/2017
Featured: Company news
Novus Investments is delighted to be appointed an Inspire Partner
We are delighted that Novus’s unique SME business offering has been recognised and engaged by Inspire the Business Growth Network by Wessex Chambers. This now gives Inspire the...
05/12/2017